Trial intelligence / Profile preview

Fruquintinib + TAS-102 with or without SBRT for third-line or later metastatic colorectal cancer

ChiCTR2300070877Phase 2Recruiting

Sponsor

Ningbo No. 2 Hospital

Start

Apr 2023

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1